Geode Capital Management, LLC Castle Biosciences Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 624,683 shares of CSTL stock, worth $16.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

624,683

Previous 617,679 1.13%

Holding current value

$16.6 Million

Previous $13.4 Million 32.49%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$17.4 - $31.47 $121,869 - $220,415	7,004 Added 1.13%	624,683 $17.8 Million
Q2 2024 Aug 09, 2024	BUY	$18.84 - $24.94 $737,491 - $976,276	39,145 Added 6.77%	617,679 $13.4 Million
Q1 2024 May 13, 2024	BUY	$18.06 - $25.3 $224,287 - $314,200	12,419 Added 2.19%	578,534 $12.8 Million
Q4 2023 Feb 13, 2024	BUY	$12.19 - $22.43 $364,225 - $670,185	29,879 Added 5.57%	566,115 $12.2 Million
Q3 2023 Nov 13, 2023	BUY	$13.28 - $20.3 $511,970 - $782,605	38,552 Added 7.75%	536,236 $9.06 Million
Q2 2023 Aug 11, 2023	BUY	$11.66 - $26.0 $148,431 - $330,980	12,730 Added 2.62%	497,684 $6.83 Million
Q1 2023 May 15, 2023	BUY	$19.47 - $28.49 $375,517 - $549,486	19,287 Added 4.14%	484,954 $11 Million
Q4 2022 Feb 13, 2023	BUY	$18.08 - $30.0 $361,672 - $600,120	20,004 Added 4.49%	465,667 $11 Million
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $340,058 - $518,472	15,107 Added 3.51%	445,663 $11.6 Million
Q2 2022 Aug 12, 2022	BUY	$16.0 - $45.99 $472,704 - $1.36 Million	29,544 Added 7.37%	430,556 $9.45 Million
Q1 2022 May 13, 2022	BUY	$33.17 - $46.98 $506,539 - $717,431	15,271 Added 3.96%	401,012 $18 Million
Q4 2021 Feb 11, 2022	BUY	$39.06 - $67.58 $795,769 - $1.38 Million	20,373 Added 5.58%	385,741 $16.5 Million
Q3 2021 Nov 12, 2021	BUY	$60.13 - $77.6 $1.52 Million - $1.96 Million	25,293 Added 7.44%	365,368 $24.3 Million
Q2 2021 Aug 13, 2021	BUY	$50.07 - $76.78 $2.96 Million - $4.53 Million	59,033 Added 21.01%	340,075 $24.9 Million
Q1 2021 May 12, 2021	BUY	$58.92 - $97.33 $2.83 Million - $4.67 Million	48,005 Added 20.6%	281,042 $19.2 Million
Q4 2020 Feb 12, 2021	BUY	$43.6 - $73.05 $1.15 Million - $1.92 Million	26,280 Added 12.71%	233,037 $15.6 Million
Q3 2020 Nov 13, 2020	BUY	$38.47 - $52.03 $3.65 Million - $4.94 Million	94,912 Added 84.86%	206,757 $10.6 Million
Q2 2020 Aug 13, 2020	BUY	$27.28 - $43.01 $169,381 - $267,049	6,209 Added 5.88%	111,845 $4.22 Million
Q1 2020 May 14, 2020	BUY	$23.08 - $35.53 $1.08 Million - $1.67 Million	46,901 Added 79.85%	105,636 $3.15 Million
Q4 2019 Feb 13, 2020	BUY	$15.74 - $35.04 $327,454 - $728,972	20,804 Added 54.85%	58,735 $2.02 Million
Q3 2019 Nov 12, 2019	BUY	$18.09 - $27.92 $686,171 - $1.06 Million	37,931 New	37,931 $686,000

Others Institutions Holding CSTL

# of Institutions

202

Shares Held

26M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $697M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Castle Biosciences Inc Transaction History